127 related articles for article (PubMed ID: 28235634)
1. Platelet inhibition and increased phosphorylated vasodilator-stimulated phosphoprotein following sodium nitrite inhalation.
Parakaw T; Suknuntha K; Vivithanaporn P; Schlagenhauf A; Topanurak S; Fucharoen S; Pattanapanyasat K; Schechter A; Sibmooh N; Srihirun S
Nitric Oxide; 2017 Jun; 66():10-16. PubMed ID: 28235634
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated vasodilator-stimulated phosphoprotein (P-VASPSer239) in platelets is increased by nitrite and partially deoxygenated erythrocytes.
Srihirun S; Piknova B; Sibmooh N; Schechter AN
PLoS One; 2018; 13(3):e0193747. PubMed ID: 29505609
[TBL] [Abstract][Full Text] [Related]
3. Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
Borgognone A; Shantsila E; Worrall SM; Prompunt E; Loka T; Loudon BL; Chimen M; Ed Rainger G; Lord JM; Turner A; Nightingale P; Feelisch M; Kirchhof P; Lip GYH; Watson SP; Frenneaux MP; Madhani M
Cardiovasc Res; 2018 Aug; 114(10):1313-1323. PubMed ID: 29659727
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of single dose of inhaled nebulized sodium nitrite in healthy and hemoglobin E/β-thalassemia subjects.
Sirirat K; Sriwantana T; Kaewchuchuen J; Paiboonsukwong K; Fucharoen S; Ritthidej G; Parakaw T; Srihirun S; Vivithanaporn P; Sritara P; Sibmooh N
Nitric Oxide; 2019 Dec; 93():6-14. PubMed ID: 31513867
[TBL] [Abstract][Full Text] [Related]
5. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Schäfer A; Flierl U; Kobsar A; Eigenthaler M; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
[TBL] [Abstract][Full Text] [Related]
7. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
[TBL] [Abstract][Full Text] [Related]
8. Decreased phosphorylation of platelet vasodilator-stimulated phosphoprotein in periodontitis--a role of periodontal pathogens.
Laky M; Assinger A; Esfandeyari A; Bertl K; Haririan H; Volf I
Thromb Res; 2011 Aug; 128(2):155-60. PubMed ID: 21435699
[TBL] [Abstract][Full Text] [Related]
9. Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats.
Schäfer A; Widder J; Eigenthaler M; Ertl G; Bauersachs J
Biochem Pharmacol; 2004 Jun; 67(12):2273-9. PubMed ID: 15163558
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets.
Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K
Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165
[TBL] [Abstract][Full Text] [Related]
11. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.
Schubert P; Culibrk B; Coupland D; Scammell K; Gyongyossy-Issa M; Devine DV
Transfusion; 2012 Feb; 52(2):397-408. PubMed ID: 21827504
[TBL] [Abstract][Full Text] [Related]
12. Decreased VASP phosphorylation in platelets of male and female smokers of young age.
Assinger A; Schmid W; Volf I
Platelets; 2010; 21(8):596-603. PubMed ID: 20822337
[TBL] [Abstract][Full Text] [Related]
13. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.
Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A
PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852
[TBL] [Abstract][Full Text] [Related]
14. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibition.
Jakubowski JA; Bourguet N; Boulay-Moine D; Sugidachi A; Yamaguchi S; Barragan P; Zhou C; Moulard M
Thromb Haemost; 2012 Feb; 107(2):388-95. PubMed ID: 22186965
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
Sudo T; Ito H; Kimura Y
Platelets; 2003 Sep; 14(6):381-90. PubMed ID: 14602552
[TBL] [Abstract][Full Text] [Related]
17. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
18. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets.
Wentworth JK; Pula G; Poole AW
Biochem J; 2006 Jan; 393(Pt 2):555-64. PubMed ID: 16197368
[TBL] [Abstract][Full Text] [Related]
19. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
